维生素D与血压控制的相关性

史天珍, 王琴. 维生素D与血压控制的相关性[J]. 临床心血管病杂志, 2021, 37(11): 1047-1050. doi: 10.13201/j.issn.1001-1439.2021.11.016
引用本文: 史天珍, 王琴. 维生素D与血压控制的相关性[J]. 临床心血管病杂志, 2021, 37(11): 1047-1050. doi: 10.13201/j.issn.1001-1439.2021.11.016
SHI Tianzhen, WANG Qin. The association between vitamin D and blood pressure control[J]. J Clin Cardiol, 2021, 37(11): 1047-1050. doi: 10.13201/j.issn.1001-1439.2021.11.016
Citation: SHI Tianzhen, WANG Qin. The association between vitamin D and blood pressure control[J]. J Clin Cardiol, 2021, 37(11): 1047-1050. doi: 10.13201/j.issn.1001-1439.2021.11.016

维生素D与血压控制的相关性

  • 基金项目:

    南京医科大学第一附属医院新技术、新项目(No:YHK201704)

详细信息
    通讯作者: 王琴,E-mail:wq_chj@163.com
  • 中图分类号: R544.1

The association between vitamin D and blood pressure control

More Information
  • 目的:探索血维生素D水平与高血压患者血压控制的相关性。方法:本研究为横断面研究设计,纳入1727例因高血压进行降压治疗的患者,测量患者血压和血维生素D水平,根据血维生素D水平将患者分为维生素D正常组(血维生素D 75~250 nmol/L,338例)、维生素D不足组(血维生素D 50~74 nmol/L,610例)和维生素D缺乏组(血维生素D<50 nmol/L,779例)。多因素线性回归分析和限制性立方样条函数回归分析血维生素D水平与用药后血压控制的相关性。结果:维生素D水平正常的高血压患者收缩压和舒张压显著低于维生素D不足和维生素D缺乏患者,多因素校正混杂因素后,维生素D不足组和维生素D缺乏组较维生素D正常组收缩压分别升高1.35 mmHg(1mmHg=0.133 kPa)和4.50 mmHg(趋势检验P<0.001),舒张压分别升高1.59 mmHg和4.34 mmHg(趋势检验P<0.001)。限制性立方样条函数图显示维生素D水平与高血压进行降压治疗患者的收缩压和舒张压呈线性负相关。结论:维生素D缺乏在中国人群中常见,血维生素D水平与高血压进行降压治疗患者的收缩压和舒张压呈线性负相关。
  • 加载中
  • [1]

    中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56.

    [2]

    Brouwers S,Sudano I,Kokubo Y,et al.Arterial hypertension[J].Lancet,2021,398(10296):249-261.

    [3]

    中国居民营养与慢性病状况报告(2020年)[J].营养学报,2020,42(6):521.

    [4]

    Holick MF,Binkley NC,Bischoff-Ferrari HA,et al.Evaluation,treatment,and prevention of vitamin D deficiency:an Endocrine Society clinical practice guideline[J].J Clin Endocrinol Metab,2011,96(7):1911-1930.

    [5]

    Zhang D,Cheng C,Wang Y,et al.Effect of Vitamin D on Blood Pressure and Hypertension in the General Population:An Update Meta-Analysis of Cohort Studies and Randomized Controlled Trials[J].Prev Chronic Dis,2020,17:E3.

    [6]

    van Ballegooijen AJ,Gansevoort RT,Lambers-Heerspink HJ,et al.Plasma 1,25-Dihydroxyvitamin D and the risk of developing hypertension:the prevention of renal and vascular end-stage disease study[J].Hypertension,2015,66(3):563-570.

    [7]

    Forman JP,Giovannucci E,Holmes MD,et al.Plasma 25-hydroxyvitamin D levels and risk of incident hypertension[J].Hypertension,2007,49(5):1063-1069.

    [8]

    张强,王淑辉,杨丽红,等.原发性高血压患者血清25羟基维生素D水平与血压变异性及昼夜节律的关系[J].中华高血压杂志,2016,24(3):250-256.

    [9]

    Del PR,Wright JT,Monaco A,et al.Vitamin D and blood pressure control among hypertensive adults:results from NHANES 2001-2014[J].J Hypertens,2020,38(1):150-158.

    [10]

    Xiang W,Kong J,Chen S,et al.Cardiac hypertrophy in vitamin D receptor knockout mice:role of the systemic and cardiac renin-angiotensin systems[J].Am J Physiol Endocrinol Metab,2005,288(1):E125-E132.

    [11]

    杨青艳,钟萍.维生素D缺乏与高血压病的相关性研究进展[J].实用医院临床杂志,2021,18(2):191-193.

    [12]

    van Ballegooijen AJ,Kestenbaum B,Sachs MC,et al.Association of 25-hydroxyvitamin D and parathyroid hormone with incident hypertension:MESA(Multi-Ethnic Study of Atherosclerosis)[J].J Am Coll Cardiol,2014,63(12):1214-1222.

    [13]

    罗梦莹,邹德玲.维生素D对冠心病的发生及病变程度的影响[J].临床心血管病杂志,2021,37(6):537-541.

    [14]

    Chiu KC,Chu A,Go VL,et al.Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction[J].Am J Clin Nutr,2004,79(5):820-825.

    [15]

    Wee CL,Mokhtar SS,Singh K,et al.Vitamin D deficiency attenuates endothelial function by reducing antioxidant activity and vascular eNOS expression in the rat microcirculation[J].Microvasc Res,2021:104227.

  • 加载中
计量
  • 文章访问数:  674
  • PDF下载数:  2
  • 施引文献:  0
出版历程
收稿日期:  2021-07-06

目录